Clinical trials
Phase 1/2 Melanoma trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 10 |
| Active, not recruiting | 6 |
| Recruiting | 5 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BioInvent International AB | 2 |
| Eisai Inc. | 2 |
| Genmab | 2 |
| Immodulon Therapeutics Ltd | 2 |
| NuCana plc | 2 |
| Pfizer | 2 |
| Achilles Therapeutics UK Limited | 1 |
| Array Biopharma, now a wholly owned subsidiary of Pfizer | 1 |
| BioNTech SE | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 35 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Neoplasm Metastasis | 8 |
| Neoplasms | 6 |
| Stomach Neoplasms | 6 |
| Ovarian Neoplasms | 5 |
| Sarcoma | 5 |
| Triple Negative Breast Neoplasms | 5 |
| Carcinoma, Renal Cell | 4 |
| Colorectal Neoplasms | 4 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.